ContraFect Corporation ContraFect Corporation Nasdaq: CFRX

Navigate ContraFect Corporation

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Lysins
    • Amurins
    • Publications / Posters
    • Video Library
  • Pipeline
    • Overview
    • Exebacase
    • CF-370
    • Gram-negative Lysins
    • Amurins
  • Investors & Media
    • Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Analyst Coverage
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

Management Team

Investors & Media

  • Home
  • Investors & Media
  • Company Information
  • Management Team
Investors & Media

Investors & Media

  • Overview
  • News / Events
  • Presentations
  • Company Information
    • Profile
    • Management Team
    • Contacts
    • FAQ
    • Logos
  • Financial Information
  • Analyst Coverage
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
Roger J. Pomerantz, M.D., F.A.C.P. President, Chief Executive Officer and Chairman of the Board Roger J. Pomerantz, M.D., F.A.C.P. View Bio
Cara Cassino, M.D. Chief Medical Officer and Executive Vice President of Research and Development Cara Cassino, M.D. View Bio
Michael Messinger, CPA Chief Financial Officer Michael Messinger, CPA View Bio
Natalie Bogdanos J.D. General Counsel, Corporate Secretary & Data Protection Officer Natalie Bogdanos J.D. View Bio
Jane E. Ambler, Ph.D. Vice President of Clinical Microbiology Jane E. Ambler, Ph.D. View Bio
Nancy Capra Vice President of Program Management and Development Operations Nancy Capra View Bio
Kristina Haeckl, RAC Senior Vice President of Regulatory Affairs and Quality Systems Kristina Haeckl, RAC View Bio
Matthew Salamone, SPHR, PHR Vice President of Human Resources Matthew Salamone, SPHR, PHR View Bio
Raymond Schuch, Ph.D. Vice President of Research Raymond Schuch, Ph.D. View Bio
Gary Woodnutt, Ph.D. Senior Vice President of Translational Sciences and Preclinical Development Gary Woodnutt, Ph.D. View Bio
© 2022 ContraFect Corporation. All Rights Reserved.
Copyright Privacy Policy Expanded Access Policy Disclaimer Site Map
LinkedIn Twitter